Abbott Laboratories (ABT) Intangibles (2009 - 2026)
Abbott Laboratories (ABT) reported Intangibles of $17.9 billion for Q1 2026, up 185.5% on a YoY basis from $6.3 billion in Q1 2025, and up 223.47% sequentially from $5.5 billion in Q4 2025.
Abbott Laboratories (ABT) Intangibles (2009 - 2026) Analysis & Trends
Abbott Laboratories (ABT) has 18 years of Intangibles data on file, last reported at $17.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Intangibles rose 185.5% year-over-year to $17.9 billion; the trailing twelve-month figure through Mar 2026 stood at $17.9 billion (up 185.5% YoY), and the FY2025 full-year result was $5.5 billion, down 16.86% from the prior year.
- Intangibles advanced to $17.9 billion in Q1 2026, from $5.5 billion in the prior quarter.
- In the past five years, Intangibles ranged from a high of $27.7 billion in Q1 2022 to a low of $5.5 billion in Q4 2025.
- A 5-year average of $10.0 billion and a median of $8.8 billion in 2023 frame the typical range for Intangibles.
- Across the five-year window, Intangibles surged 1067.92% in 2022 and plunged 63.88% in 2023, its largest moves.
- Tracing ABT's Intangibles over 5 years: stood at $10.5 billion in 2022, then dropped by 15.68% to $8.8 billion in 2023, then decreased by 24.59% to $6.6 billion in 2024, then retreated by 16.86% to $5.5 billion in 2025, then surged by 223.47% to $17.9 billion in 2026.
- Business Quant data shows ABT's Intangibles at $17.9 billion in Q1 2026, $5.5 billion in Q4 2025, and $5.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.88 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 5.52 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 10.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 7.06 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.14 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.91 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 882.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 1.62 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.88 Bn |
| Dec 31, 2025 | 5.53 Bn |
| Sep 30, 2025 | 5.60 Bn |
| Jun 30, 2025 | 5.92 Bn |
| Mar 31, 2025 | 6.26 Bn |
| Dec 31, 2024 | 6.65 Bn |
| Sep 30, 2024 | 7.35 Bn |
| Jun 30, 2024 | 7.83 Bn |
| Mar 31, 2024 | 8.30 Bn |
| Dec 31, 2023 | 8.82 Bn |
| Sep 30, 2023 | 9.28 Bn |
| Jun 30, 2023 | 9.83 Bn |
| Mar 31, 2023 | 10.01 Bn |
| Dec 31, 2022 | 10.45 Bn |
| Sep 30, 2022 | 10.85 Bn |
| Jun 30, 2022 | 11.59 Bn |
| Mar 31, 2022 | 27.70 Bn |
| Dec 31, 2021 | 12.74 Bn |
| Sep 30, 2021 | 929.00 Mn |
| Jun 30, 2021 | 13.68 Bn |